Global Asthma Market 2014-2018

Published: Sep 2014 Pages: 91 SKU: IRTNTR4048

About Asthma and its Categories
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors. The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.
TechNavio's analysts forecast the Global Asthma Market to grow at a CAGR of 4.50 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Asthma market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various class of drugs used in the treatment of asthma:
• Bronchodilators
• Leukotriene antagonists
• Mast cell stabilizers
• Immunosuppressants
TechNavio's report, the Global Asthma Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Asthma Market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA       

Key Vendors
• AstraZeneca
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Merck
• Novartis

Other Prominent Vendors
 • Abbott
• Actavis
• Amgen
• AptarGroup
• Astellas
• Aurobindo
• Biotest
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Cipla
• Cytos
• Dainippon Sumitomo
• Dr. Reddy's Laboratories
• Glenmark
• Medicinova
• Mylan
• Ono Pharmaceutical
• Orchid Chemicals and Pharmaceuticals
• Perrigo
• Pfizer
• Ranbaxy
• Rottapharm Madaus
• Skyepharma
• Sosei
• Sunovion
• Teva
• Theravance
• Vectura

Market Driver
• Rise in Prevalence of Disease
• For a full, detailed list, view our report

Market Challenge
• Unknown Etiology of Disease
• For a full, detailed list, view our report

Market Trend
• Popularity of Combination Therapies
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Class of Drugs
07.1 Bronchodilators
07.2 Leukotriene Antagonists
07.3 Mast Cell Stabilizers
07.4 Immunosuppressants
07.5 Combination of LABA/ICS
08. Global Bronchodilators Market
08.1 Market Overview
08.2 Market Size and Forecast
09. Global Leukotriene Antagonists Market
09.1 Market Overview
09.2 Market Size and Forecast
10. Global Mast Cell Stabilizers Market
10.1 Market Overview
10.2 Market Size and Forecast
11. Global Immunosuppressants Market
11.1 Market Overview
11.2 Market Size and Forecast
12. Global Combination of ICS/LABA Market
12.1 Market Overview
12.2 Market Size and Forecast
13. Global Other Asthma Drugs Market
13.1 Market Overview
13.2 Market Size and Forecast
14. Geographical Segmentation
14.1 Global Asthma Market by Geographical Segmentation 2013-2018
14.2 Asthma Market in the US
14.2.1 Market Overview
14.2.2 Market Size and Forecast
14.3 Asthma Market in the Russia
14.3.1 Market Overview
14.3.2 Market Size and Forecast
14.4 Asthma Market in the India
14.4.1 Market Overview
14.4.2 Market Size and Forecast
15. Rate of Incidence and Prevalence
16. Buying Criteria
17. Market Growth Drivers
18. Drivers and their Impact
19. Market Challenges
20. Impact of Drivers and Challenges
21. Market Trends
22. Trends and their Impact
23. Vendor Landscape
23.1 Competitive Scenario
23.1.1 Key News
23.1.2 Mergers and Acquisitions
23.2 Market Share Analysis 2013
23.2.1 AstraZeneca
23.2.2 GlaxoSmithKline
23.2.3 Merck
23.2.4 Novartis
23.2.5 Roche
23.3 Other and Future Prominent Vendors
24. Pipeline Portfolio
25. Key Vendor Analysis
25.1 AstraZeneca plc
25.1.1 Key Facts
25.1.2 Business Description
25.1.3 Business Segmentation
25.1.4 Business Strategy
25.1.5 Revenue by Business Segmentation
25.1.6 Revenue Comparison 2011-2013
25.1.7 Sales Revenue by Geographical Segmentation
25.1.8 Key Developments
25.1.9 SWOT Analysis
25.2 Hoffmann La Roche
25.2.1 Key Facts
25.2.2 Business Overview
25.2.3 Business Segmentation by Revenue 2013
25.2.4 Business Segmentation by Revenue 2012 and 2013
25.2.5 Geographical Segmentation by Revenue 2013
25.2.6 Business Strategy
25.2.7 Recent Developments
25.2.8 SWOT Analysis
25.3 GlaxoSmithKline
25.3.1 Key Facts
25.3.2 Business Overview
25.3.3 Business Segmentation
25.3.4 Business Segmentation by Revenue 2012 and 2013
25.3.5 Sales by Geography
25.3.6 Pipeline Products
25.3.7 Business Strategy
25.3.8 Key Information
25.3.9 SWOT Analysis
25.4 Merck
25.4.1 Key Facts
25.4.2 Business Overview
25.4.3 Business Segmentation by Revenue 2013
25.4.4 Business Segmentation by Revenue 2012 and 2013
25.4.5 Sales by Geography
25.4.6 Business Strategy
25.4.7 Key Developments
25.4.8 SWOT Analysis
25.5 Novartis
25.5.1 Key Facts
25.5.2 Business Overview
25.5.3 Business Segmentation by Revenue 2013
25.5.4 Business Segmentation by Revenue 2012 and 2013
25.5.5 Sales by Geography
25.5.6 Business Strategy
25.5.7 Key Developments
25.5.8 SWOT Analysis
26. Other Reports in this Series

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

market

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis